Eosinophilic Pustular Folliculitis in Children after Stem Cell Transplantation: An Eruption Distinct from Graft-Versus-Host Disease

Pediatr Dermatol. 2017 May;34(3):326-330. doi: 10.1111/pde.13108. Epub 2017 Mar 20.

Abstract

Eosinophilic pustular folliculitis (EPF) is a rare cutaneous disorder that typically occurs in three clinical contexts: men, individuals who are immunosuppressed or have human immunodeficiency virus, and infants. A fourth subtype occurring 2 to 3 months after hematopoietic stem cell transplantation (HSCT) has recently been described in several adults. We report two cases of EPF arising in children after HSCT. It is important to recognize this form of EPF after HSCT and differentiate it from graft-versus-host disease since it responds readily to topical steroids and appears to have an excellent prognosis.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Diagnosis, Differential
  • Eosinophilia / diagnosis*
  • Eosinophilia / drug therapy
  • Eosinophilia / etiology
  • Folliculitis / diagnosis*
  • Folliculitis / drug therapy
  • Folliculitis / etiology
  • Glucocorticoids / therapeutic use*
  • Graft vs Host Disease / diagnosis*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Infant
  • Infant, Newborn
  • Male
  • Skin / pathology
  • Skin Diseases, Vesiculobullous / diagnosis*
  • Skin Diseases, Vesiculobullous / drug therapy
  • Skin Diseases, Vesiculobullous / etiology
  • Stem Cell Transplantation / adverse effects*

Substances

  • Glucocorticoids
  • Immunosuppressive Agents

Supplementary concepts

  • Eosinophilic pustular folliculitis